Medicinsk Oxygen ”strandmøllen” (Oxygen)

When inhaled, oxygen diffuses across the alveolar membrane into the bloodstream, raising the partial pressure of arterial oxygen. This increased oxygen gradient enhances delivery of O₂ to tissues, supporting cellular metabolism and energy production, especially when the body’s natural oxygen supply is insufficient.

The dose of supplemental oxygen is individualized and determined by the prescribing clinician based on the patient’s oxygen saturation, underlying condition, and clinical response. The prescriber sets the flow rate, concentration, and duration appropriate for each patient.

Oxygen therapy is generally considered safe during pregnancy and breastfeeding when medically indicated, as it does not cross the placenta in harmful amounts. However, the decision to use supplemental oxygen should be made by a qualified healthcare professional who can weigh the benefits and any potential risks.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Medicinsk Oxygen Strandmøllen is a high‑purity medical gas supplied in standard cylinders, comparable to other pharmaceutical‑grade oxygen products. Its quality conforms to EU standards, ensuring consistent concentration and safety. Compared with liquid oxygen systems, cylinder‑based delivery offers flexibility for short‑term or portable use without the need for specialized storage infrastructure.

Store the oxygen cylinders in a well‑ventilated, dry area away from heat sources and direct sunlight, maintaining ambient temperature below 25 °C. Keep cylinders upright, secure them to prevent tipping, and protect the regulator from damage. Follow all local regulations for compressed gas storage and handling.

The gas is administered via inhalation using appropriate delivery devices such as nasal cannulas, simple face masks, or non‑rebreather masks. The prescriber selects the flow rate and delivery system based on the patient’s oxygen needs, and healthcare staff monitor oxygen saturation throughout therapy.

Serious risks include pulmonary oxygen toxicity, which can cause lung injury, and central nervous system toxicity leading to seizures, especially at high concentrations or prolonged exposure. Fire hazards are also a concern, as enriched oxygen environments increase the flammability of surrounding materials.

Patients with untreated severe chronic carbon dioxide retention (e.g., certain COPD phenotypes) may experience worsening hypercapnia with high‑flow oxygen and should be managed carefully. Additionally, individuals with known hypersensitivity to the delivery equipment or those in environments with high fire risk should avoid use unless strict safety measures are in place.